Co-founder & CEO, Precia Group
Biography
Precia Group is a CRO co-founded by Donna Russell in 2020 to expand the number of women in research studies, especially in early phases. The company is focused on women’s reproductive health and pregnancy but will expand its service areas to include all aspects of women’s health across the lifespan. Prior to Precia Group, Russell worked in maternal health research, in the US as a Director of Research at Seattle Children’s Research Institute and globally, consulting with the Bill & Melinda Gates Foundation and other funders. She has extensive experience establishing biobanks to support pregnancy cohorts and research networks in the community-setting; and harmonizing collections across multiple networks to enable large-scale omics studies. She also serves on the board of a large community hospital affiliated with the University of Washington and has a deep understanding of how to successfully integrate research into the clinical setting to ensure high-quality, diverse, equitable studies.
Clinical Dx Showcase:
Precia Group
Session Abstract – PMWC 2023 Silicon Valley
Showcase Track S2 - January 25 9.00 A.M.-1.15 P.M.,Showcase Track S2 - January 26 9.00 A.M.-4.45 P.M.,Showcase Track S2 - January 27 9.00 A.M.-2.15 P.M.
The PMWC 2023 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative
